News

Researchers have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test could help doctors to choose alternative therapies for patients who don’t respond to the therapies normally used to treat their cancer.

Researchers have identified a regulatory RNA molecule that can help block the expression of a powerful cancer-promoting gene, MYC.

Research finds that Axitinib, a drug commonly used to treat cancer, can restore memory and cognitive function in mice that display symptoms of Alzheimer’s disease.

A study of the genetic basis of blood vessel growth finds a surprise player helping cells ace this complex feat.

Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a new study from the University of Eastern Finland and Kuopio University Hospital shows.

Researchers have profiled thousands of individual cells sampled from brain tumors. The findings and methods used represent a significant advance in cancer research, and may lead to better ways of detecting, monitoring and treating cancers.

When many mutations are combined in a cancer cell, new features can emerge. Biologists are using a mathematical approach to find important genetic interactions associated with cancer.

Researchers have uncovered a key step in the ionization of liquid water using a high-speed electron camera. This reaction is of fundamental significance to a wide range of fields, including nuclear engineering, space travel, cancer treatment and environmental remediation.

Researchers have shown that the type of cancer treatment influences vaccine response: patients undergoing chemotherapy had lower antibody levels than patients undergoing targeted therapy.

Two new papers explore the effects of copper cysteamine, a next-generation cancer photodrug, as a means to reduce radioactive doses and side effects when treating deep-seated tumor cells.